跳至主要内容
临床试验/ITMCTR2000003420
ITMCTR2000003420尚未招募1 期

Research on the mechanism of multimodal imaging effect of Taijiquan movement on the decline of subjective cognitive function based on default network

Fujian University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
60 至 75(—)
性别
All

入选标准

  • 1. Patients who meet the diagnostic criteria of SCD;
  • 2. Patients aged 60-75 years;
  • 3. There was no objective clinical damage of MCI in patients with score of Montreal cognitive function assessment scale >= 26;
  • 4. Patients who have not been engaged in regular exercise in the last six months;
  • 5. Patients with right handedness;
  • 6. Patients with informed consent and voluntary participation.

排除标准

  • 1. Hypertension patients whose blood pressure cannot be controlled;
  • 2. Patients with history of alcohol and drug abuse;
  • 3. Patients with cognitive decline caused by other reasons;
  • 4. Patients with sports contraindications and low education level who can not cooperate with the test;
  • 5. Patients with contraindications of MRI and taking drugs affecting brain imaging;
  • 6. Patients who are participating in other study trials that affect the results of this study.

研究者

发起方
Fujian University of Traditional Chinese Medicine

相似试验

招募中
不适用
inking multimodal network imaging and cognitive functioning in glioma patientsGliomabrain tumor
NL-OMON55895Vrije Universiteit Medisch Centrum275
招募中
不适用
Rein 3D PRINT MECHANICSKidney Cancer
NCT06525831University Hospital, Bordeaux50
终止
不适用
Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent GlioblastomaGlioblastoma
NCT02841332University Hospital, Toulouse6
进行中(未招募)
1 期
Phase 2a open label study of Fovista¿ (anti-PDGF agent) administered in combination with anti-VEGF therapy in subjects previously treated or treatment-naive.Subfoveal choroidal neovascularization secondary to Age-Related Macular Degeneration (AMD)MedDRA version: 20.0Level: PTClassification code 10071129Term: Neovascular age-related macular degenerationSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.1Level: LLTClassification code 10067791Term: Wet macular degenerationSystem Organ Class: 10015919 - Eye disorders
EUCTR2015-000519-42-ITIVERIC bio, Inc.32
进行中(未招募)
1 期
Role of imaging in the evaluation of anatomic alterations in neovascular Age-Related Macular Degeneration (AMD) subjects: 18 month study of Fovista® (anti-PDGF therapy) administered in combination with anti-VEGF therapySubfoveal choroidal neovascularization secondary to Age-Related Macular Degeneration (AMD)MedDRA version: 18.0 Level: PT Classification code 10071129 Term: Neovascular age-related macular degeneration System Organ Class: 10015919 - Eye disordersMedDRA version: 18.0 Level: LLT Classification code 10067791 Term: Wet macular degeneration System Organ Class: 10015919 - Eye disorders
EUCTR2015-000519-42-FROPHTHOTECH CORPORATIO32